Breadcrumb Home Business Activities Lundbeckfonden BioCapital Lundbeckfonden BioCapital Portfolio EpiTherapeutics EpiTherapeutics Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics. Lundbeckfonden BioCapital Invested 2010 Acquired by Gilead in 2015 Location Foster City, California, USA